Bordetella pertussis in infants hospitalized for acute respiratory symptoms remains a concern

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Nicolai, Ambra ^a   Nenna, Raffaella ^a   Stefanelli, Paola ^b   Carannante, Anna ^b   Schiavariello, Concetta ^a   Pierangeli, Alessandra ^c   Scagnolari, Carolina ^c   Moretti, Corrado ^a   Papoff, Paola ^a   Bonci, Enea ^a   Ferrara, Marianna ^a   Papasso, Stefano ^a   Midulla, Fabio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Bordetella pertussis; Bronchiolitis; Infants; Vaccine

Indexed keywords

ACUTE RESPIRATORY TRACT DISEASE; APNEA; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BORDETELLA PERTUSSIS; BRONCHIOLITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYANOSIS; DISEASE ASSOCIATION; EOSINOPHIL COUNT; EPIDEMIC; FEMALE; FEVER; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; INFANT; LYMPHOCYTE COUNT; MALE; MOLECULAR DYNAMICS; NONHUMAN; OUTCOME ASSESSMENT; PERTUSSIS; PRN2 GENE; PTXA1 GENE; PTXP3 GENE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RETROSPECTIVE STUDY; SEASONAL VARIATION; VIRUS IDENTIFICATION; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEWBORN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; VIROLOGY; WHOOPING COUGH;

BORDETELLA PERTUSSIS; DISEASE OUTBREAKS; FEMALE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; WHOOPING COUGH;

EID: 84887563183     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-526     Document Type: Article

References (32)

1. Bamberger ES, Srugo I. What's new in pertussis?. Eur J Pediatr 2008, 167:133-139. 10.1007/s00431-007-0548-2, 2151776, 17668241.
2. Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in the Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 1998, 66:670-675. 107955, 9453625.
3. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol 2005, 18:326-382.
4. Cassiday P, Sanden G, Heuvelman K, Mooi F, Bisgard KM, Popovic T. Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999. J Infect Dis 2000, 182:1402-1408. 10.1086/315881, 11023463.
5. Caro V, Njamkepo E, Van Amersfoorth SC, Mooi FR, Advani A, Hallander HO, He Q, Mertsola J, Riffelmann M, Vahrenholz C, Von König CH, Guiso N. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microb Infect 2005, 7:976-982.
6. Hallander H, Advani A, Riffelmann M, von König CH, Caro V, Guiso N, Mooi FR, Gzyl A, Kaltoft MS, Fry NK, Mertsola J, He Q. Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J Clin Microbiol 2007, 45:3257-3262. 10.1128/JCM.00864-07, 2045341, 17699646.
7. Walsh PF, Kimmel L, Feola M, Tran T, Lim C, De Salvia L, Pusavat J, Michaelson S, Nguyen TA, Emery K, Mordechai E, Adelson ME. Prevalence of Bordetella pertussis and Bordetella parapertussis in infants presenting to the emergency department with bronchiolitis. J Emerg Med 2011, 40:256-261. 10.1016/j.jemermed.2008.04.048, 19062227.
8. Walsh P, Overmeyer C, Kimmel L, Feola M, Pusavat J, Nguyen TA, Kuan S, Emery K, Rosengreen M, Mordechai E, Adelson ME. Prevalence of Bordetella pertussis and Bordetella parapertussis in samples submitted for RSV screening. West J Emerg Med 2008, 9:135-140. 2672259, 19561728.
9. Legru E, Lubrano M, Lemee L, Marguet C. Bronchiolites à VRS du nourrisson: chercher la coqueluche associée? Acute RSV bronchiolitis: Should we be looking for pertussis?. Arch Pédiatrie 2009, 16:283-284.
10. Aoyama T, Ide Y, Watanabe J, Takeuchi Y, Imaizumi A. Respiratory failure caused by dual infection with Bordetella pertussis and respiratory syncytial virus. Acta Paedia Japon 1996, 38:282-285.
11. Guinto-Ocampo H, Bennett JE, Attia MW. Predicting pertussis in infants. Pediatr Emerg Care 2008, 1:16-20.
12. Castagnini LA, Munoz FM. Clinical characteristics and outcomes of neonatal pertussis: a comparative study. J Pediatr 2010, 156:498-500. 10.1016/j.jpeds.2009.10.013, 20056236.
13. Tozzi AE, Pandolfi E, Pastore Celentano L, Massari M, Salmaso S, Ciofi degli Atti ML. Comparison of pertussis surveillance system in Europe. Vaccine 2007, 25:291-297. 10.1016/j.vaccine.2006.07.023, 16920230.
14. Tozzi AE, Celentano LP, Ciofi degli Atti ML, Salmaso S. Diagnosis and management of pertussis. Can Med Assoc J 2005, 172:509-515.
15. Midulla F, Scagnolari C, Bonci E, Pierangeli A, Antonelli G, De Angelis D, Berardi R, Moretti C. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch dis child 2010, 95:35-41. 10.1136/adc.2008.153361, 19822538.
16. Xu Y, Xu Y, Hou Q, Yang R, Zhang S. Triplex real-time PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis. Acta Path Micro Im 2010, 118:685-691.
17. Templeton KE, Scheltinga SA, van der Zee A, Diederen BM, van Kruijssen A, Goossens H, Kuijper E, Claas EC. Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J Clin Microbiol 2003, 41(9):4121-4126. 10.1128/JCM.41.9.4121-4126.2003, 193783, 12958235.
18. Mooi FR, Hallander H, von König CH W, Hoet B, Guiso N. Epidemiological typing of Bordetella pertussis isolates: recommendations for standard methodology. Eur J Clin Microbiol 2000, 19:174-181.
19. Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman KJ, de Greeff SC, Diavatopoulos D, Teunis P, Nagelkerke N, Mertsola J. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 2009, 15:1206-1213. 10.3201/eid1508.081511, 2815961, 19751581.
20. Halasa NB, O'Shea A, Shi JR, LaFleur BJ, Edwards KM. Poor immune response to a birth dose of diphtheria, tetanus and acellular pertussis vaccine. J Pediatr 2008, 153:327-332. 10.1016/j.jpeds.2008.03.011, 3773719, 18534242.
21. Broutin H, Viboud C, Grenfell BT, Miller MA, Rohani P. Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. P Roy Soc Lond B Bio 2010, 277:3239-3245.
22. Guiso N, Liese J, Plotkin S. Global Pertussis Initiative: relation derived from the fourth regional roundtable, France, April 14-15. Landes Bioscience 2010, 7:481-488.
23. CDC Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMRW 2011, 60(1):13-15. CDC.
24. Belloni C, De Silvestri A, Tinelli C, Avanzini MA, Marconi M, Strano F, Rondini G, Chirico G. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 2003, 111:1042-1045. 10.1542/peds.111.5.1042, 12728086.
25. Quinello C, Quintilio W, Carneiro-Sampaio M, Palmeira P. Passive acquisition of protective antibodies reactive with Bordetella pertussis in newborns via placental transfer and breast-feeding. Scand J Immunol 2010, 72:66-73.
26. Nafstad P, Jaakkola JJ, Hagen JA, Botten G, Kongerud J. Breastfeeding, maternal smoking and lower respiratory tract infections. Eur Respir J 1996, 9:2623-2629. 10.1183/09031936.96.09122623, 8980979.
27. Cherry JD, Heininger U. Pertussis and other Bordetella infections. Textbook of pediatric infectious diseases. Volume 1 2004, 1588-1608. Philadelphia, Pa: WB Saunders Co, Feigin RD, Cherry JD, Demmler GJ, Kaplan S, 6.
28. Guiso N. Bordetella pertussis and pertussis vaccines. Clin Infect Dis 2009, 49:1565-1569. 10.1086/644733, 19839747.
29. Cohen SG, Sapp TM, Chiampi PN. Eosinophil leukocyte responses and hypersensitivity reactions in the Bordetella pertussis-treated mouse. J Allergy 1970, 46:205-215. 10.1016/0021-8707(70)90024-9, 4318636.
30. Tjabbes T, de Wied M. The influence of the ventral posterior hypothalamus on Bordetella pertussis vaccine-induced eosinophilia. Arch Intern Pharm Ther 1962, 135:218-222.
31. King AJ, van der Lee S, Mohangoo A, van Gent M, van der Ark A, van de Waterbeemd B. Genome-Wide Gene Expression Analysis of Bordetella pertussis Isolates Associated with a Resurgence in Pertussis: Elucidation of Factors Involved in the Increased Fitness of Epidemic Strains. PLoS One 2013, 8(6):e66150. 10.1371/journal.pone.0066150, 3679012, 23776625.
32. Shinall MC, Peters TR, Zhu Y, Chen Q, Poehling KA. Potential impact of acceleration of the pertussis vaccine primary series for infants. Pediatrics 2008, 122:1021-1026. 10.1542/peds.2007-3025, 18977982.